The Putative Antilipogenic Role of NRG4 and ERBB4: First Expression Study on Human Liver Samples

Background: Epidermal growth factor receptor 4 (ERBB4) and neuregulin 4 (NRG4) have been shown to reduce steatosis and prevent the development of non-alcoholic steatohepatitis in mouse models, but little to nothing is known about their role in non-alcoholic fatty liver disease (NA...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Frontiers in Bioscience-Landmark
المؤلفون الرئيسيون: Maria Bograya, Maria Vulf, Anastasia Minchenko, Natalia Gazatova, Georgy Kuznetsov, Natalia Todosenko, Larisa Volkova, Pavel Ivanov, Larisa Litvinova
التنسيق: مقال
اللغة:الإنجليزية
منشور في: IMR Press 2024-12-01
الموضوعات:
erbb4
nrg4
obesity
nafld
steatosis
nash
الوصول للمادة أونلاين:https://www.imrpress.com/journal/FBL/29/12/10.31083/j.fbl2912414

الانترنت

https://www.imrpress.com/journal/FBL/29/12/10.31083/j.fbl2912414

مواد مشابهة